Compile Data Set for Download or QSAR
Report error Found 64 Enz. Inhib. hit(s) with all data for entry = 11850
TargetTyrosine-protein kinase BTK(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652841(US20240059694, Compound I-25)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652842((R)-N-(7-(1-(1-acryloylpiperidin-3)-4-amino-1H-pyr...)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652839(US20240059694, Compound I-23)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK3(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652834(US20240059694, Compound I-22 | US20240059694, Comp...)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652840(US20240059694, Compound I-24)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652845(US20240059694, Compound I-32)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652846(US20240059694, Compound I-33)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK3(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652845(US20240059694, Compound I-32)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652843(US20240059694, Compound I-28)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652844(US20240059694, Compound I-31)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652833(US20240059694, Compound I-21 | US20240059694, Comp...)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK3(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652832(US20240059694, Compound I-16)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652834(US20240059694, Compound I-22 | US20240059694, Comp...)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK3(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652833(US20240059694, Compound I-21 | US20240059694, Comp...)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652831(US20240059694, Compound I-15)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK3(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652830(US20240059694, Compound I-14)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652832(US20240059694, Compound I-16)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK3(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652831(US20240059694, Compound I-15)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652833(US20240059694, Compound I-21 | US20240059694, Comp...)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK3(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652836(US20240059694, Compound I-20)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652834(US20240059694, Compound I-22 | US20240059694, Comp...)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK3(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652833(US20240059694, Compound I-21 | US20240059694, Comp...)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652835(US20240059694, Compound I-19)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK3(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652834(US20240059694, Compound I-22 | US20240059694, Comp...)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652836(US20240059694, Compound I-20)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK3(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652835(US20240059694, Compound I-19)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652825(US20240059694, Compound I-9)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652826(US20240059694, Compound I-10)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652823(US20240059694, Compound I-7)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK3(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652822(US20240059694, Compound I-6)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652824(US20240059694, Compound I-8)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK3(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652823(US20240059694, Compound I-7)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652829(US20240059694, Compound I-13)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652830(US20240059694, Compound I-14)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK3(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652829(US20240059694, Compound I-13)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652827(US20240059694, Compound I-11)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK3(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652826(US20240059694, Compound I-10)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652828(US20240059694, Compound I-12)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK3(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652827(US20240059694, Compound I-11)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652817(US20240059694, Compound I-1)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652818(US20240059694, Compound I-2)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652847(US20240059694, Compound I-34)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM50357312(IBRUTINIB | US9181263, 1 | US9108973, Ref 1 | US92...)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652821(US20240059694, Compound I-5)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652822(US20240059694, Compound I-6)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652819(US20240059694, Compound I-3)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652820(US20240059694, Compound I-4)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK3(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652840(US20240059694, Compound I-24)
Affinity DataIC50: 275nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK3(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652824(US20240059694, Compound I-8)
Affinity DataIC50: 275nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK3(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652841(US20240059694, Compound I-25)
Affinity DataIC50: 275nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

Displayed 1 to 50 (of 64 total ) | Next | Last >>
Jump to: